Medical devices, healthcare technology and the business of care
510(k) clearance · K261565

FAQ (FAQ 411)

Foreo, Inc. · Decision date Oct 22, 2026

MEDTECHLEDGER EXPLANATIONK261565

What did the FDA decide?

The FDA record for K261565 lists Foreo, Inc. of Las Vegas, Nevada, as applicant for a traditional 510(k) under the device name FAQ™ (FAQ 411). The listed decision is SESE, dated 2026-10-22, with a recorded submission date of 05/11/2026. The record carries product code NFO and specialty Neurology, and the review documentation is listed as a Summary. SESE denotes a 510(k) clearance rather than a PMA approval.

The source does not describe the device's components, intended use, technology, or any changed item, and it does not identify a predicate device or a relationship to another application. The excerpt also does not state the basis for the Neurology specialty or product code NFO assignment. No clinical, efficacy, or labeling conclusions can be drawn from these fields, and the substantive content of the Summary document remains unexamined here.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Neurology
Decision date
Oct 22, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K261565
Regulatory pathway
510(k) premarket notification
Applicant
Foreo, Inc.
Product code
NFO
Decision code
SESE
Decision date
Oct 22, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Stimulator, Transcutaneous Electrical, Aesthetic Purposes.

Applicant
Foreo, Inc.
Product code
NFO
FDA device class
2

FDA decision timeline

  1. K261565 received

    Application receipt date recorded by FDA.

  2. K261565 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code NFO

Product / regulatory recordCompanyPathwayDecision dateSource
Foreo, Inc.510(k) clearanceOct 26, 2026FDA
Guangdong Newdermo Biotech Co., Ltd.510(k) clearanceSep 16, 2026FDA
Xtreem Pulse, LLC510(k) clearanceSep 11, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Foreo, Inc.

Headquarters
Not reported
Brand website
foreo.com
FDA applicant address
Las Vegas, NV

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records